Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-044565

SOLENO THERAPEUTICS INC · SLNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David D O'Toole
Officer — See Remarks
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 5:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock OptionF1,F2,F3,F4,F5,F6$4.66May 15, 2015A30,000AJun 15, 2015May 15, 2025Common Stock30,00030,000D

Explanation of responses

Remarks

Senior Vice President, Chief Financial Officer